These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9041101)

  • 1. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor.
    Dunne MJ; Kane C; Shepherd RM; Sanchez JA; James RF; Johnson PR; Aynsley-Green A; Lu S; Clement JP; Lindley KJ; Seino S; Aguilar-Bryan L
    N Engl J Med; 1997 Mar; 336(10):703-6. PubMed ID: 9041101
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sulfonylurea receptors].
    Ishihara H; Oka Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():661-5. PubMed ID: 12430300
    [No Abstract]   [Full Text] [Related]  

  • 3. The molecular basis for familial persistent hyperinsulinemic hypoglycemia of infancy.
    Thomas PM; Cote GJ; Wohllk N; Mathew PM; Gagel RF
    Proc Assoc Am Physicians; 1996 Jan; 108(1):14-9. PubMed ID: 8834059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pas de deux or more: the sulfonylurea receptor and K+ channels.
    Philipson LH; Steiner DF
    Science; 1995 Apr; 268(5209):372-3. PubMed ID: 7716539
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy.
    Thomas PM; Cote GJ; Wohllk N; Haddad B; Mathew PM; Rabl W; Aguilar-Bryan L; Gagel RF; Bryan J
    Science; 1995 Apr; 268(5209):426-9. PubMed ID: 7716548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemic hypoglycemia of infancy. Recent insights into ATP-sensitive potassium channels, sulfonylurea receptors, molecular mechanisms, and treatment.
    Sperling MA; Menon RK
    Endocrinol Metab Clin North Am; 1999 Dec; 28(4):695-708, vii. PubMed ID: 10609115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy.
    Thomas PM; Wohllk N; Huang E; Kuhnle U; Rabl W; Gagel RF; Cote GJ
    Am J Hum Genet; 1996 Sep; 59(3):510-8. PubMed ID: 8751851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for a dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy: a family with documented hyperinsulinemia in two generations.
    Hufnagel M; Eichmann D; Stieh J; Santer R
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2215-6. PubMed ID: 9626165
    [No Abstract]   [Full Text] [Related]  

  • 9. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.
    Otonkoski T; Ammälä C; Huopio H; Cote GJ; Chapman J; Cosgrove K; Ashfield R; Huang E; Komulainen J; Ashcroft FM; Dunne MJ; Kere J; Thomas PM
    Diabetes; 1999 Feb; 48(2):408-15. PubMed ID: 10334322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
    Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy, not linked to the sulfonylurea receptor locus.
    Kukuvitis A; Deal C; Arbour L; Polychronakos C
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1192-4. PubMed ID: 9100595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy.
    MacFarlane WM; Chapman JC; Shepherd RM; Hashmi MN; Kamimura N; Cosgrove KE; O'Brien RE; Barnes PD; Hart AW; Docherty HM; Lindley KJ; Aynsley-Green A; James RF; Docherty K; Dunne MJ
    J Biol Chem; 1999 Nov; 274(48):34059-66. PubMed ID: 10567373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinism: molecular aetiology of focal disease.
    Ryan F; Devaney D; Joyce C; Nestorowicz A; Permutt MA; Glaser B; Barton DE; Thornton PS
    Arch Dis Child; 1998 Nov; 79(5):445-7. PubMed ID: 10193261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor.
    Katz LE; Ferry RJ; Stanley CA; Collett-Solberg PF; Baker L; Cohen P
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3117-24. PubMed ID: 10487673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia.
    Fournet JC; Verkarre V; De Lonlay P; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
    Ann Endocrinol (Paris); 1998; 59(6):485-91. PubMed ID: 10189991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The causes of neonatal hypoglycemia.
    Stanley CA; Baker L
    N Engl J Med; 1999 Apr; 340(15):1200-1. PubMed ID: 10202173
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of genes encoding the pancreatic beta-cell ATP-sensitive K+ channel in persistent hyperinsulinemic hypoglycemia of infancy in Japanese patients.
    Someya T; Miki T; Sugihara S; Minagawa M; Yasuda T; Kohno Y; Seino S
    Endocr J; 2000 Dec; 47(6):715-22. PubMed ID: 11228046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia.
    Verkarre V; Fournet JC; de Lonlay P; Gross-Morand MS; Devillers M; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
    J Clin Invest; 1998 Oct; 102(7):1286-91. PubMed ID: 9769320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PHHI (persistent hyperinsulinemic hypoglycemia of infancy)].
    Nagashima K
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():637-40. PubMed ID: 12430295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.